Skip to content

Research plan for the evaluation of minimally invasive circumcision surgery for breast tumors assisted by ultrasound dynamic imaging AI navigation and breast fixation device

Research plan for the evaluation of minimally invasive circumcision surgery for breast tumors assisted by ultrasound dynamic imaging AI navigation and breast fixation device

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071189
Enrollment
Unknown
Registered
2023-05-07
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast tumor

Interventions

AI Navigation Group:Breast ultrasound dynamic video AI navigation
AI+breast fixation group:Implementing minimally invasive circumcision surgery assisted by breast ultrasound dynamic video AI navigation and breast fixation device
control group:Routine circumcision

Sponsors

People's Hospital of Liaoning province
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Breast ultrasound indicates a single tumor and the tumor boundary is clear under ultrasound; ? The distance between the upper edge of the tumor and the skin is = 0.4cm, and the maximum diameter of the tumor is = 0.5cm and = 3.0cm; ? Tumor ultrasound BI-RADS: 4a and below, patients are anxious and do not accept observation; ? Individuals over 40 years old need to undergo molybdenum target examination or magnetic resonance imaging, and it is confirmed that there is no suspicious malignancy; ? The blood routine test, coagulation function, liver and kidney function were normal. The fasting blood glucose of patients with diabetes was controlled at 7.8-10.0mmol/L, without heart and lung complications, and without breast surgery history.

Exclusion criteria

Exclusion criteria: ? Menstrual period or tendency to bleed; ? Patients with concomitant heart and lung diseases cannot tolerate surgery; ? Tumors within a range of 1.0cm around the nipple. ? Half a year after surgery, ultrasound examination revealed suspicious tumor residue, but refused a second surgery.

Design outcomes

Primary

MeasureTime frame
Tumor residue rate;

Secondary

MeasureTime frame
operative time;Intraoperative bleeding volume;

Countries

china

Contacts

Public Contactcuijianchun

People's Hospital of Liaoning province

cjc7162003@aliyun.com+86 17702489995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026